We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGN icon
601
Organon & Co
OGN
$3.55B
$1.82M 0.01%
55,582
+4,904
+10% +$157K
EJFAU
602
DELISTED
EJF Acquisition Corp. Unit
EJFAU
$1.82M 0.01%
175,000
-150,000
-46% -$1.5M
PHR icon
603
Phreesia
PHR
$671M
$1.79M 0.01%
28,945
+13,660
+89% +$911K
FND icon
604
Floor & Decor
FND
$6.14B
$1.76M 0.01%
14,604
+6,078
+71% +$725K
JWSM.U
605
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
$1.76M 0.01%
175,000
MPWR icon
606
Monolithic Power Systems
MPWR
$63B
$1.74M 0.01%
3,593
+49
+1% +$22.3K
ODFL icon
607
Old Dominion Freight Line
ODFL
$47.1B
$1.73M 0.01%
12,128
+6,852
+130% +$951K
FACT.U
608
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
$1.68M 0.01%
170,000
CRC icon
609
California Resources
CRC
$4.38B
$1.67M 0.01%
+40,760
New +$1.33M
SKY icon
610
Champion Homes
SKY
$4.58B
$1.67M 0.01%
+27,707
New +$1.64M
IAS
611
DELISTED
Integral Ad Science
IAS
$1.6M 0.01%
77,341
-48,196
-38% -$950K
FLL icon
612
Full House Resorts
FLL
$83.8M
$1.57M 0.01%
148,205
-98,016
-40% -$837K
ET icon
613
Energy Transfer Partners
ET
$69.5B
$1.56M 0.01%
162,945
BLFS icon
614
BioLife Solutions
BLFS
$1.56B
$1.56M 0.01%
36,779
+1,330
+4% +$64K
MBAC.U
615
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
$1.55M 0.01%
150,000
FRTA
616
DELISTED
Forterra, Inc
FRTA
$1.53M 0.01%
65,000
AMX icon
617
America Movil
AMX
$77.2B
$1.53M 0.01%
86,500
RGEN icon
618
Repligen
RGEN
$7.11B
$1.51M 0.01%
5,244
+2,907
+124% +$746K
ARGUU
619
DELISTED
Argus Capital Corp. Unit
ARGUU
$1.51M 0.01%
+150,000
New +$1.52M
UMC icon
620
CALL
United Microelectronic
UMC
$43.6B
$1.51M 0.01%
+132,000
New +$1.42M
ITMR
621
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$1.51M 0.01%
49,925
-65,836
-57% -$1.46M
CPUH.U
622
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$1.5M 0.01%
150,000
LVRAU
623
DELISTED
Levere Holdings Corp. Unit
LVRAU
$1.5M 0.01%
150,000
HLAHU
624
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Unit
HLAHU
$1.5M 0.01%
150,000
KAHC.U
625
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
$1.5M 0.01%
150,000

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.